Dr. Calabrese is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-2400Fax+1 216-844-2875
Education & Training
- National Institutes of Health Clinical CenterResidency, Psychiatry, 1984 - 1986
- Cleveland Clinic FoundationResidency, Psychiatry, 1980 - 1984
- Ohio State University College of MedicineClass of 1980
- Xavier UniversityB.S., Biology, Summa Cum Laude, 1972 - 1976
Certifications & Licensure
- OH State Medical License 1981 - 2023
- MD State Medical License 1984 - 1986
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Distinguished Life Fellow American Psychiatric Association, 2016
- America's Top Doctors Castle Connolly, 2008-2014
- Highly Cited as being one of the world’s most influential scientific minds within the section entitled: “Psychiatry/Psychology” Thompson Reuters, 2014
- Join now to see all
Clinical Trials
- Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Start of enrollment: 2002 Jul 01
- Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD) Start of enrollment: 2011 Apr 01
- Sequential Multiple Assignment Treatment for Bipolar Disorder Start of enrollment: 2011 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 927 citationsCanadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bi...Lakshmi N. Yatham, Sidney H. Kennedy, Sagar V. Parikh, Ayal Schaffer, David J. Bond
Bipolar Disorders. 2018-03-01 - 319 citationsInternational meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk lociCaroline M. Nievergelt, Adam X. Maihofer, Torsten Klengel, Elizabeth G. Atkinson, Chia-Yen Chen
Nature Communications. 2019-10-08 - 17 citationsClinical correlates of acute bipolar depressive episode with psychosis.Marco Antonio Knob Caldieraro, Louisa G. Sylvia, Steven Dufour, Samantha L. Walsh, Jessica Janos
Journal of Affective Disorders. 2017-08-01
Journal Articles
- Subthreshold PTSD and PTSD in a Prospective‐Longitudinal Cohort of Military Personnel: Potential Targets for Preventive InterventionsIsrael Liberzon, Marijo B Tamburrino, Katherine M Keyes, Sandro Galea, Joseph R Calabrese, Depression and Anxiety
- Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar I disorder: a double-blind, placebo-controlled, randomized withdrawal studyCalabrese JR, Sanchez R, Jin D, Amatniek J, Cox K, Johnson B, Perry, Hertal P, Salzman PM, McQuate RD, Nyilas M, Carson WH, J Clin Psychiatry, 1/31/2017
- Depression Severity and Quality of Life of Qualified and Unqualified Patients with a Mood Disorder for a Research Stuy Targeting Anhedonia in a Clinical SampleGao K, Sweet J, Su M, Calabrese J, Asian J Psychiatry, 1/1/2017
- Join now to see all
Books/Book Chapters
Lectures
- Monotherapy and Adjunctive Latuda for treatment of bipolar depression.Sau Paulo, Brazil - 1/18/2016
- Vincent van Gogh: Biography, Family History, and Artistic Genius.Cleveland Clinic - 1/1/2016
- Recognition and Treatment of Bipolar DisorderColombia; CARICAM; Mexico; Ecuador; Chile; Brazil; Argentina - 1/29/2015
- Join now to see all
Other
- Six subtle signs of depression you should never ignore.Calabrese JR
1/31/2016 - Westside Arts Festival Shines Light on Mental Illness and Addiction.Calabrese JR
1/19/2016 - Long-Acting Injectable Aripiprazole as a Potential Maintenance Treatment for Bipolar I Disorder.Calabrese JR, Otsuka and Lundbeck Data at ACNP Annual Meeting
1/17/2016 - Join now to see all
Press Mentions
- FDA Approves Abilify Maintena for Bipolar I Disorder Monotherapy TreatmentAugust 8th, 2017
- FDA Approves First Monthly Injectable for Bipolar DisorderJuly 31st, 2017
- LAI Aripiprazole Found to Reduce Recurrence of Mood EpisodesMarch 16th, 2017
- Join now to see all
Grant Support
- Psychosocial Intervention To Promote Treatment Adherence In CmchNational Institute Of Mental Health2007
- Phenomenology And Identification Of Juvenile BPD In A Community SettingNational Institute Of Mental Health2007
- Combination Therapy In Dual Diagnosis Rapid Cycling BPD In Both The Tertiary CareNational Institute Of Mental Health2007
- Bipolar Disorder Across The Life SpanNational Institute Of Mental Health2003–2007
- Combination Therapy In Bipolar Rapid CyclingNational Institute Of Mental Health2002–2004
- Valproate Versus Lithium In Bipolar Rapid CyclingNational Institute Of Mental Health1995–1999
- Valproate And Lithium In The Prophylaxis Of The Manic Phase Of Bipolar DisorderNational Institute Of Mental Health1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: